SC
SCLXW
Scilex Holding Co
$0.1360
0.00%
$1.3M
No data for this timeframe.
Vol
Market Cap$1.3M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$25.00
Inst. Activity1 buys / 0 sells
SEC Reports5
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001820190·Prev Close $0.1360
Recent Activity
Jun 4, 2026
dividend
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
<p>PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “C
Jun 2, 2026
SEC
Scilex Holding Company filed an S-3 shelf registration to register up to 2,083,067 primary shares issuable upon exercise
S-3 — Impact 6/10
May 26, 2026
SEC
Scilex Holding Co's Form S-3 shelf registration (File No. 333-295109) was declared effective by the SEC on May 22, 2026.
EFFECT — Impact 6/10
May 5, 2026
SEC
Scilex's indirect subsidiary ACEA Therapeutics agreed to sell 100% of ACEA Pharma to Phoenix Asia Holdings in exchange f
8-K — Impact 8/10
Inst.
BANK OF AMERICA CORP — ADD
265 shares ($25.00)
Latest Reports
BEARISH
S-3
6/10
Scilex Holding Company filed an S-3 shelf registration to register up to 2,083,067 primary shares issuable upon exercise
Jun 2, 2026
BEARISH
EFFECT
6/10
Scilex Holding Co's Form S-3 shelf registration (File No. 333-295109) was declared effective by the SEC on May 22, 2026.
May 26, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $25.00 | ADD |
1 institutional holders with $25.00 total value (265 shares) as of 2025-Q4. Top holders: BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 265 | $25.00 | 100.0% | ADD +60.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | ADD | 165 | 265 | +60.6% | $25.00 | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 1 mixed, 1 neutral. Avg impact: 6.0/10.
BEARISH
S-3
6/10
Scilex Holding Company filed an S-3 shelf registration to register up to 2,083,067 primary shares is
Jun 2, 2026
BEARISH
EFFECT
6/10
Scilex Holding Co's Form S-3 shelf registration (File No. 333-295109) was declared effective by the
May 26, 2026
BULLISH
8-K
8/10
Scilex's indirect subsidiary ACEA Therapeutics agreed to sell 100% of ACEA Pharma to Phoenix Asia Ho
May 5, 2026
MIXED
8-K
6/10
Scilex Holding Co entered a binding term sheet to contribute $120 million to Datavault AI Inc. for b
Apr 28, 2026
NEUTRAL
S-3
4/10
Scilex Holding Co (SCLXW) has filed a shelf registration (Form S-3) to offer up to $500 million in v
Apr 16, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 4, 2026
dividend
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
<p>PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gen
May 22, 2026
dividend
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
<p>PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gene
May 5, 2026
m_and_a
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
<p>PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gene
May 4, 2026
dividend
Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026
<p>PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-gene
Mar 13, 2026
other
Scilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related Parties
<p align="left">PALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovati